Latest Distributions News

Nufarm Finance (NZ) Limited reported a modest 1.1% rise in net profit to $20.53 million for the year ended September 2025, alongside increased distributions to security holders and maintained strong liquidity backed by its parent company.

Sietel Limited’s preliminary final report for FY2025 reveals a 47% drop in net profit and a 24% fall in total revenues, underscoring a challenging year for the investment management firm.

Accent Group reported a modest 1.6% rise in FY25 owned sales to $1.46 billion and a net profit after tax of $57.7 million, while outlining ambitious FY26 plans including the launch of Sports Direct stores in Australia and New Zealand.

Accent Group reports modest sales growth but margin pressures in FY26 H1, announces MySale closure and new Sports Direct store launch.

Infini Resources has expanded its drilling program at the Portland Creek Uranium Project, revealing multiple uranium-bearing zones across a broad corridor. Early results suggest a large, district-scale uranium system with promising polymetallic potential.

RLF AgTech reports a robust 34% increase in Australian revenue for the four months to October 2025, driven by stronger distributor engagement and promising trial results. The company is poised for growth as it enters its critical January–June 2026 sales season with an expanded national footprint.

QuickFee Limited has announced a shareholder-approved return of capital totaling approximately A$28.5 million, funded by proceeds from the sale of its US Pay Now and Connect businesses. Shareholders will receive 7.5 cents per share, with payments scheduled for early December.

Coventry Group reports a challenging FY25 with revenue slipping 1.7% and EBITDA plunging 40.9%, but early FY26 results show promising recovery driven by cost cuts and ERP system stabilisation.

OMG Group has secured its maiden purchase order for premium SANDAI matcha in Australia, marking a promising start to a new high-margin revenue channel ahead of FY26.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

ECS Botanics has achieved a milestone with direct-to-consumer sales exceeding 60% of total revenue, driven by the launch of innovative sugar-free THC gummies and a strategic distribution partnership.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.